Literature DB >> 12508376

A new cytokine: the possible effect pathway of methionine enkephalin.

Xin-Hua Liu1, Dong-Ai Huang, Fei-Yi Yang, Yan-Sheng Hao, Guo-Guang Du, Ping-Feng Li, Gang Li.   

Abstract

AIM: To investigate experimentally the effects of methionine enkephalin on signal transduction of mouse myeloma NS-1 cells.
METHODS: The antigen determinate of delta opioid receptor was designed in this lab and the polypeptide fragment of antigen determinate with 12 amino acids residues was synthesized. Monoclonal antibody against this peptide fragment was prepared. Proliferation of Mouse NS-1 cells treated with methionine enkephalin of 1 x 10(-6) mol x L(-1) was observed. The activities of protein kinase A (PKA) and protein kinase C (PKC) were measured and thereby the mechanism of effect of methionine enkephalin was postulated.
RESULTS: The results demonstrated that methionine enkephalin could enhance the proliferation of NS-1 cells and the effect of methionine enkephalin could be particularly blocked by monoclonal antibody. The activity of PKA was increased in both cytosol and cell membrane. With reference to PKC, the intracellular activity of PKC in NS-1 cells was elevated at 1 x 10(-7) mol x L(-1) and then declined gradually as the concentration of methionine enkephalin was raised. The effects of methionine enkephalin might be reversed by both naloxone and monoclonal antibody.
CONCLUSION: Coupled with the findings, it indicates that the signal transduction systems via PKA and PKC are involved in the effects of methionine enkephalin by binding with the traditional opioid receptors,and therefore resulting in different biological effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12508376      PMCID: PMC4728236          DOI: 10.3748/wjg.v9.i1.169

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors.

Authors:  K Chaturvedi; P Bandari; N Chinen; R D Howells
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.

Authors:  J Shen; A Benedict Gomes; A Gallagher; K Stafford; B C Yoburn
Journal:  Synapse       Date:  2000-12-01       Impact factor: 2.562

Review 3.  Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.

Authors:  J G Liu; K J Anand
Journal:  Brain Res Brain Res Rev       Date:  2001-12

4.  Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding.

Authors:  M C Pepin; S Y Yue; E Roberts; C Wahlestedt; P Walker
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

5.  Methionine-enkephalin alteration of mitogenic and mixed lymphocyte culture responses in zinc-deficient mice.

Authors:  G Li; P J Fraker
Journal:  Zhongguo Yao Li Xue Bao       Date:  1989-05

6.  Tolerance to morphine at the mu-opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine.

Authors:  Z Wang; W Sadée
Journal:  Eur J Pharmacol       Date:  2000-02-18       Impact factor: 4.432

7.  Location of regions of the opioid receptor involved in selective agonist binding.

Authors:  K Fukuda; S Kato; K Mori
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

8.  The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.

Authors:  Meng-Sen Li; Ping-Feng Li; Shi-Peng He; Guo-Guang Du; Gang Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

9.  Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.

Authors:  S Chakrabarti; P Y Law; H H Loh
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

10.  Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.

Authors:  T Avidor-Reiss; M Bayewitch; R Levy; N Matus-Leibovitch; I Nevo; Z Vogel
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

View more
  3 in total

1.  Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles.

Authors:  Wei Wang; Gen-Jin Yang; Ju Zhang; Chen Chen; Zhen-Yu Jia; Jia Li; Wei-Dong Xu
Journal:  Arthritis Res Ther       Date:  2016-10-22       Impact factor: 5.156

2.  Plasma metabolite profiling reveals potential biomarkers of giant cell tumor of bone by using NMR-based metabolic profiles: A cross-sectional study.

Authors:  Wei Wang; Xilin Liu; Juan Wu; Xia Kang; Qingyun Xie; Jun Sheng; Wei Xu; Da Liu; Wei Zheng
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

Review 3.  Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis.

Authors:  Chiara Rizzo; Federica Camarda; Denise Donzella; Lidia La Barbera; Giuliana Guggino
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.